Entac Medical Inc.
Entac develops AI-driven acoustic wearables predicting patient adverse events, with its first launched device, PrevisEA, targeting an $8 billion market and a pipeline for multiple high-value healthcare sectors exceeding $20 billion.
- PrevisEA Commitments: 5 hospitals systems (63 hospitals) $41M revenue oppy
- In review: 6 systems (71 hospitals) - $39M opportunity. Commitment due
- Engaged: 7 systems (120 hospitals) - $67M opportunity - Expected in 2025.
